Source: Stem Cell Reviews and Reports. Unidade: IQ
Subjects: RECEPTORES, COVID-19, QUIMIOTAXIA, CÉLULAS-TRONCO, NEUTRÓFILOS
ABNT
PETIZ, Lyvia Lintzmaier et al. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, v. 17, p. 241–252, 2021Tradução . . Disponível em: http://dx.doi.org/10.1007/s12015-021-10129-7. Acesso em: 06 jul. 2022.APA
Petiz, L. L., Ratajczak, M. Z., Ulrich, H., Glaser, T., & Scharfstein, J. (2021). P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation. Stem Cell Reviews and Reports, 17, 241–252. doi:10.1007/s12015-021-10129-7NLM
Petiz LL, Ratajczak MZ, Ulrich H, Glaser T, Scharfstein J. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2022 jul. 06 ] Available from: http://dx.doi.org/10.1007/s12015-021-10129-7Vancouver
Petiz LL, Ratajczak MZ, Ulrich H, Glaser T, Scharfstein J. P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation [Internet]. Stem Cell Reviews and Reports. 2021 ; 17 241–252.[citado 2022 jul. 06 ] Available from: http://dx.doi.org/10.1007/s12015-021-10129-7